0001209191-22-003405.txt : 20220114 0001209191-22-003405.hdr.sgml : 20220114 20220114210025 ACCESSION NUMBER: 0001209191-22-003405 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220112 FILED AS OF DATE: 20220114 DATE AS OF CHANGE: 20220114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAMSAY DAVID A CENTRAL INDEX KEY: 0001283292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 22533331 MAIL ADDRESS: STREET 1: HALOZYME THERAPEUTICS, INC. STREET 2: 11588 SORRENTO VALLEY ROAD, #17 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 JONES ROAD, SUITE 400 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-715-3600 MAIL ADDRESS: STREET 1: 201 JONES ROAD, SUITE 400 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-12 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001283292 RAMSAY DAVID A C/O LA JOLLA PHARMACEUTICAL COMPANY 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 1 0 0 0 Stock Option (Right to Buy) 4.81 2022-01-12 4 A 0 30000 0.00 A 2032-01-12 Common Stock 30000 30000 D The stock options vest and become exercisable on January 12, 2023 subject to the Reporting Person's continued service to the Issuer through such date. /s/ Michael Hearne, by power of attorney for David A. Ramsay 2022-01-14